0HCK.LSE Align Technology, Inc.

Healthcare Medical Instruments & Supplies London Exchange
- USD
Market cap
-
P/E
17.1x
P/B
-
ROE
11.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0HCK.LSE undervalued?

Graham number

The Graham number of Align Technology, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Align Technology, Inc. fundamental analysis

No fundamental analysis for Align Technology, Inc. yet.

Align Technology, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of …

Full company profile